Fernández-Galván Aurora, Rodríguez-Jiménez Pedro, González-Sixto Beatriz, Abalde-Pintos María Teresa, Butrón-Bris Beatriz
Dermatology Department, Hospital Universitario La Princesa, Diego de León St. 62, 28006 Madrid, Spain.
Dermatology Department, Hospital Ruber Internacional, 28034 Madrid, Spain.
Cancers (Basel). 2024 Jun 4;16(11):2135. doi: 10.3390/cancers16112135.
Basal Cell Carcinoma (BCC) is the most common type of cancer among the white population. Individuals with fair skin have an average lifetime risk of around 30% for developing BCC, and there is a noticeable upward trend in its incidence rate. The principal treatment objectives for BCC involve achieving the total excision of the tumor while maximizing the preservation of function and cosmesis. Surgery is considered the treatment of choice for BCC for two main reasons: it allows for the highest cure rates and facilitates histological control of resection margins. However, in the subgroup of patients with low-risk recurrence or medical contraindications for surgery, new non-surgical treatment alternatives can provide an excellent oncological and cosmetic outcome. An evident and justified instance of these local therapies occurred during the COVID-19 pandemic, a period when surgical interventions carried out in hospital settings were not a viable option.
基底细胞癌（BCC）是白种人群中最常见的癌症类型。皮肤白皙的个体患基底细胞癌的终生平均风险约为30%，且其发病率呈明显上升趋势。基底细胞癌的主要治疗目标是在最大程度保留功能和美观的同时实现肿瘤的完全切除。手术被认为是基底细胞癌的首选治疗方法，主要有两个原因：它能实现最高的治愈率，并有助于对切除边缘进行组织学控制。然而，在复发风险低或有手术医学禁忌证的患者亚组中，新的非手术治疗选择可以提供出色的肿瘤学和美容效果。在2019年冠状病毒病（COVID-19）大流行期间，这些局部治疗方法有一个明显且合理的应用实例，在那段时间里，在医院环境中进行手术干预并非可行选择。
